The von Hippel-Lindau tumour suppressor protein: new perspectives
被引:64
作者:
Ohh, M
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USAHarvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
Ohh, M
[1
]
Kaelin, WG
论文数: 0引用数: 0
h-index: 0
机构:Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
Kaelin, WG
机构:
[1] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Adult Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
来源:
MOLECULAR MEDICINE TODAY
|
1999年
/
5卷
/
06期
关键词:
D O I:
10.1016/S1357-4310(99)01481-1
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germline mutations of the VHL tumour suppressor gene. The VHL gene product, pVHL, forms multiprotein complexes that contain elongin B, elongin C and Cul-2, and negatively regulates hypoxia-inducible mRNAs, pVHL is suspected to play a role in ubiquitination given the similarity of elongin C and Cul-2 with Skp1 and Cdc53, respectively, pVHL can also interact with fibronectin and is required for the assembly of a fibronectin matrix, Finally, pVHL, at least indirectly, plays a role in the ability of cells to exit the cell cycle. Thus, pVHL is a tumour suppressor protein that regulates angiogenesis, extracellular matrix formation and the cell cycle.
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
Aso, T
;
Haque, D
论文数: 0引用数: 0
h-index: 0
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
Haque, D
;
Barstead, RJ
论文数: 0引用数: 0
h-index: 0
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
Barstead, RJ
;
Conaway, RC
论文数: 0引用数: 0
h-index: 0
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
Conaway, RC
;
Conaway, JW
论文数: 0引用数: 0
h-index: 0
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
Aso, T
;
Haque, D
论文数: 0引用数: 0
h-index: 0
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
Haque, D
;
Barstead, RJ
论文数: 0引用数: 0
h-index: 0
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
Barstead, RJ
;
Conaway, RC
论文数: 0引用数: 0
h-index: 0
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA
Conaway, RC
;
Conaway, JW
论文数: 0引用数: 0
h-index: 0
机构:
OKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USAOKLAHOMA MED RES FDN, PROGRAM MOL & CELL BIOL, OKLAHOMA CITY, OK 73104 USA